Frankfurt - Delayed Quote USD

Applied DNA Sciences, Inc. (UDJ.F)

Compare
0.0000 -4.6600 (-100.00%)
At close: April 25 at 8:59 AM GMT+2
Currency in USD All numbers in thousands
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Total Revenue
3,398.0490
13,367.4430
18,168.6770
9,027.7380
1,931.4970
--
Cost of Revenue
2,547.0730
7,834.0110
13,115.0370
4,544.8320
827.8230
--
Gross Profit
850.9760
5,533.4320
5,053.6400
4,482.9060
1,103.6740
--
Operating Expense
15,775.3070
16,486.7220
19,023.4030
17,009.8060
13,638.6730
--
Operating Income
-14,924.3310
-10,953.2900
-13,969.7630
-12,526.9000
-12,534.9990
--
Net Non Operating Interest Income Expense
126.1960
75.3320
7.2000
13.6750
-115.8300
--
Other Income Expense
7,407.9210
855.0420
5,692.5040
-1,765.2140
-378.0750
--
Pretax Income
-7,390.2140
-10,022.9160
-8,270.0590
-14,278.4390
-13,028.9040
--
Net Income Common Stockholders
-7,521.1290
-9,947.0590
-8,377.9960
-14,286.4420
-13,030.0610
--
Diluted NI Available to Com Stockholders
-7,521.1290
-9,947.0590
-8,377.9960
-14,286.4420
-13,030.0610
--
Basic EPS
-7.50
-15.20
-18.60
-41.40
-66.40
--
Diluted EPS
-7.50
-15.20
-18.60
-41.40
-66.40
--
Basic Average Shares
1,542.8620
653.7700
448.3850
345.8490
195.9530
--
Diluted Average Shares
1,542.8620
653.7700
448.3850
345.8490
195.9530
--
Total Operating Income as Reported
-14,924.3310
-10,953.2900
-13,969.7630
-13,348.6410
-12,534.9990
--
Total Expenses
18,322.3800
24,320.7330
32,138.4400
21,554.6380
14,466.4960
--
Net Income from Continuing & Discontinued Operation
-7,288.0420
-9,947.0590
-8,267.8910
-14,286.4420
-13,027.2190
--
Normalized Income
-14,710.7770
-10,801.4590
-14,007.7000
-12,529.9840
-13,027.2190
--
Interest Income
126.1960
75.3320
7.2000
13.6750
--
--
Interest Expense
115.8300
--
--
--
115.8300
162.4320
Net Interest Income
126.1960
75.3320
7.2000
13.6750
-115.8300
--
EBIT
-14,924.3310
-10,953.2900
-13,969.7630
-12,526.9000
-12,534.9990
--
EBITDA
-13,975.2100
-9,591.0410
-12,679.2830
-11,682.4620
-12,249.2690
--
Reconciled Cost of Revenue
2,547.0730
7,834.0110
13,115.0370
4,544.8320
827.8230
--
Reconciled Depreciation
949.1210
1,362.2490
1,290.4800
844.4380
285.7300
--
Net Income from Continuing Operation Net Minority Interest
-7,288.0420
-9,947.0590
-8,267.8910
-14,286.4420
-13,027.2190
--
Total Unusual Items Excluding Goodwill
7,422.7350
854.4000
5,739.8090
-1,756.4580
--
--
Total Unusual Items
7,422.7350
854.4000
5,739.8090
-1,756.4580
--
--
Normalized EBITDA
-21,397.9450
-10,445.4410
-18,419.0920
-9,926.0040
-12,249.2690
--
9/30/2019 - 9/29/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade